Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - A randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

Philipp Harter, Patricia Pautier, Els Van Nieuwenhuysen, Alexander Reuss, Andres Redondo, Kristina Lindemann, Christian Kurzeder, Edgar Petru, Florian Heitz, Jalid Sehouli, Nikolaus Degregorio, Pauline Wimberger, Alexander Burges, Nadin Cron, Jonathan Ledermann, Domenica Lorusso, Xavier Paoletti, Frederik Marme

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - A randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)'. Together they form a unique fingerprint.

Medicine & Life Sciences